documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

12 rows where docket_id = "FDA-1996-N-0006" and posted_year = 2002 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), last_modified (date)

document_type 3

posted_year 1

  • 2002 · 12 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1996-N-0006-0015 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 OMB Revisions of the Final Rule re Additional Criteria for Classifying OTC Drugs as Generally Recognized as Safe and Effective; Final Rule Supporting & Related Material Reference (internal unless indicated) 2002-09-20T04:00:00Z 2002 9     2015-03-19T15:17:07Z   0 0 09000064804f9978
FDA-1996-N-0006-0014 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Reference 1 FDA/CDER re Additional Criteria for Classifying OTC Drugs as Generally Recognized as Safe and Effective; Final Rule Supporting & Related Material Reference (internal unless indicated) 2002-09-20T04:00:00Z 2002 9     2015-03-19T15:21:48Z   0 0 09000064804f9977
FDA-1996-N-0006-0013 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER to Ciba Specialty Chemicals Other Letter(s) 2002-07-17T04:00:00Z 2002 7     2015-03-19T18:07:53Z   0 0 09000064804f9976
FDA-1996-N-0006-0005 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Response Letter from FDA/CDER to Buchanan Ingersoll Professional Corporation Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-03-19T18:40:20Z   0 0 09000064804f9969
FDA-1996-N-0006-0010 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER to Ciba Specialty Chemicals Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-03-20T13:54:01Z   0 0 09000064804f9973
FDA-1996-N-0006-0009 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER to Rural Industries Research & Development Corporation Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-06-19T20:38:35Z   0 0 09000064804f9972
FDA-1996-N-0006-0007 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Response from FDA/CDER to Bass & Ullman, P.C. Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-06-19T20:38:06Z   0 0 09000064804f996e
FDA-1996-N-0006-0006 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Response from FDA/CDER to BASF AG [Morgan, Lewis & Bockius, LLP] Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-03-19T20:19:26Z   0 0 09000064804f996d
FDA-1996-N-0006-0011 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER to EM Industries, Inc. Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-03-19T17:39:10Z   0 0 09000064804f9974
FDA-1996-N-0006-0008 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Response from FDA/CDER to The Procter & Gamble Company Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-03-19T20:35:10Z   0 0 09000064804f9971
FDA-1996-N-0006-0012 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER to Covington & Burling Other Letter(s) 2002-06-26T04:00:00Z 2002 6     2015-06-19T20:40:35Z   0 0 09000064804f9975
FDA-1996-N-0006-0004 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Notice of Final Rule re Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded Rule Final Rule 2002-01-25T05:00:00Z 2002 1     2015-05-05T15:08:46Z   0 0 09000064804f9964

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);